share_log
Reuters ·  Apr 2 11:07
Neumora Therapeutics Inc : BofA Global Research Cuts to Underperform From Buy; Cuts Price Objective to $1 From $7
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 301
Write a comment